A bioelectronic device developed by U.K. startup Ceryx Medical Ltd. has shown potential to restore cardiac performance in preclinical studies. The Cardiff, Wales-based company published data showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results